Naloxone nasal spray

Ended Awarded

Contract number
VA77017F0688
Awardee
Awarding agency
Obligated
$452,280

Award facts

Contract value 100% obligated
$452,280.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Veterans Integrated Service Network 12 Veterans Health Administration, Department of Veterans Affairs
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Wayne, PA 19087, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the provision of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has a ceiling value of $452,280.00 and an ultimate completion date of March 10, 2017.

Emergent Devices, Inc. is a subsidiary of Emergent BioSolutions, a multinational specialty biopharmaceutical company. The company holds multiple federal contracts and grant sub-awards to supply NARCAN nasal spray and other naloxone formulations to various government agencies, including the Department of Veterans Affairs, Department of Homeland Security, Department of Health and Human Services, and Department of Justice, among others. This contract is not designated as a set-aside.

Emergent Devices, Inc. also holds a larger $11.8 million multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs for Schedule 65 IB pharmaceuticals, drugs, and hematology-related products, as well as a $250,000 single-award Blanket Purchase Agreement with the Department of the Navy Criminal Investigative Service for NARCAN nasal spray. These indefinite delivery vehicles demonstrate the federal government's ongoing commitment to ensuring a reliable supply of opioid overdose reversal medications across multiple agencies and departments.

Quick answers

Who was awarded contract VA77017F0688?

VA77017F0688 was awarded to Emergent Devices, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on March 1, 2017.

How much is contract VA77017F0688 worth?

The government has obligated $452,280 on VA77017F0688.

Which agency awarded contract VA77017F0688?

Veterans Integrated Service Network 15 (Veterans Health Administration) awarded VA77017F0688, with funding from Veterans Integrated Service Network 12 (Veterans Health Administration).

Is contract VA77017F0688 an order under another contract?

Yes. VA77017F0688 is a delivery order under V797D70052, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA77017F0688 competed?

The extent of competition for VA77017F0688 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award